{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-165886","form_type":"8-K","ticker":"AVIR","cik":"0001593899","company_name":"Atea Pharmaceuticals, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.138586+00:00","generated_at":"2026-06-01T02:51:13.455097+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Atea Pharmaceuticals re-elects two Class I directors; Berger receives 48% withhold votes","bullets":["Franklin Berger elected with 30.5M for, 28.3M withheld (48% withhold); Sommadossi elected with 40.8M for, 18.1M withheld.","KPMG LLP ratified as auditor for FY2024: 62.3M for, 6.5M against, 5.6M abstain.","Say-on-pay proposal approved on advisory basis: 42.9M for, 15.5M against, 0.4M abstain.","88.3% of outstanding shares voted (74.4M of 84.3M shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-165886","json":"https://secwatch.observer/filing/0001193125-24-165886.json","markdown":"https://secwatch.observer/filing/0001193125-24-165886.md","text":"https://secwatch.observer/filing/0001193125-24-165886.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/0001193125-24-165886-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593899/000119312524165886/d891172d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:51:13.455097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}